Scp Investment, LP Cyma Bay Therapeutics, Inc. Transaction History

Scp Investment, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$10.88 - $14.52 $1.74 Million - $2.32 Million	-160,000 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$10.66 - $14.38 $533,000 - $719,000	-50,000 Reduced 23.81%	160,000 $2.15 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $1.89 Million - $3.18 Million	210,000 New	210,000 $2.73 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Scp Investment, LP, based on Form 13F filings with the SEC.

Stay updated on Scp Investment, LP with notifications on news.